Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
230.26
-6.19 (-2.62%)
At close: Nov 20, 2026, 4:00 PM EST
230.62
+0.36 (0.16%)
After-hours: Nov 20, 2026, 7:30 PM EST
Jazz Pharmaceuticals (JAZZ) Oncology Revenue Breakdown
| Date | Rylaze Enrylaze | Zepzelca | Modeyso | Defitellio Defibtrotide | Vyxeos | Erwinaze |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | 417.66M | 401.64M | 187.24M | 228.97M | 126.73M | - |
| Jun 30, 2026 | 411.23M | 376.54M | 137.17M | 220.02M | 130.31M | - |
| Mar 31, 2026 | 412.39M | 345.28M | 88.97M | 206.13M | 143.77M | - |
| Dec 31, 2025 | 402.92M | 307.31M | 47.57M | 199.39M | 146.71M | - |
| Sep 30, 2025 | 396.25M | 295.20M | 11.03M | 198.17M | 165.23M | - |
| Jun 30, 2025 | 395.16M | 301.75M | - | 212.24M | 161.96M | - |
| Mar 31, 2025 | 402.33M | 308.25M | - | 209.55M | 160.12M | - |
| Dec 31, 2024 | 410.85M | 320.32M | - | 216.57M | 162.60M | - |
| Sep 30, 2024 | 411.11M | 316.00M | - | 210.00M | 156.26M | - |
| Jun 30, 2024 | 417.19M | 308.15M | - | 191.91M | 151.77M | - |
| Mar 31, 2024 | 411.05M | 297.45M | - | 192.60M | 142.82M | - |
| Dec 31, 2023 | 394.23M | 289.53M | - | 184.00M | 147.50M | - |
| Sep 30, 2023 | 373.45M | 287.49M | - | 173.57M | 130.85M | - |
| Jun 30, 2023 | 342.11M | 279.82M | - | 175.29M | 131.09M | - |
| Mar 31, 2023 | 313.37M | 277.76M | - | 183.88M | 130.92M | - |
| Dec 31, 2022 | 281.66M | 269.91M | - | 194.29M | 127.98M | - |
| Sep 30, 2022 | 265.64M | 262.78M | - | 196.15M | 132.48M | - |
| Jun 30, 2022 | 212.80M | 264.17M | - | 204.40M | 137.10M | - |
| Mar 31, 2022 | 139.85M | 251.81M | - | 197.80M | 134.66M | 28.31M |
| Dec 31, 2021 | 85.63M | 246.81M | - | 197.93M | 134.06M | 69.38M |